Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
02/2012
02/07/2012US8110378 Nucleic acids encoding DCRS5
02/07/2012US8110202 Synthetic vaccine for tick control
02/07/2012US8110189 Using monoclonal antibody specific to biliary glycoprotein as tool in treatment and prevention of cell proliferative, autoimmune, immunodeficiency and transplant rejection disorders
02/07/2012CA2497640C Medical device having hydration inhibitor
02/07/2012CA2385312C Compositions and methods for preventing and treating transplant rejection
02/07/2012CA2301964C Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
02/07/2012CA2273196C Isolated mammalian monocyte cell genes; related reagents
02/02/2012WO2012015979A2 Hmgb1-derived peptides enhance immune response to antigens
02/02/2012WO2012015972A1 Compositions and methods for inhibition of the jak pathway
02/02/2012WO2012015704A2 Peripherally restricted faah inhibitors
02/02/2012WO2012014994A1 Naphthalene derivative
02/02/2012WO2012014993A1 Agent for increasing translation initiation factor or translation elongation factor, and use thereof for medical purposes
02/02/2012WO2012014978A1 Immune adjuvant
02/02/2012WO2012014945A1 Novel nucleic acid having adjuvant activity and use thereof
02/02/2012WO2012014805A1 Nitric oxide generation regulator
02/02/2012WO2012014492A1 Immunity inducer
02/02/2012WO2012014114A1 Matrix metalloproteinase inhibitors
02/02/2012WO2012013249A1 Dentin matrix protein 1 (dmp1) for use in pharmaceutical compositions
02/02/2012WO2012012872A1 Recombinant bacterium and uses thereof
02/02/2012WO2012012851A1 Recombinant neisseria meningitidis por a porin proteins.
02/02/2012WO2012012843A1 Modulators of protease activated receptors
02/02/2012US20120030839 Expression and High-Throughput Screening of Complex Expressed DNA Libraries in Filamentous Fungi
02/02/2012US20120029473 Use of 5c8 mab and direct induction of regulatory cd8+ t cells to establish permanent and specific transplantation tolerance
02/02/2012US20120029173 Attenuated salmonella enterica serovar paratyphi a and uses thereof
02/02/2012US20120029082 Nutritional or therapeutic compositions to increase bodily glutathione levels
02/02/2012US20120029056 Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjögren's syndrome
02/02/2012US20120029034 Novel calcium salts of Compound as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents
02/02/2012US20120029026 Pyridine derivative
02/02/2012US20120029019 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
02/02/2012US20120029016 Indoles Useful in the Treatment of Inflammation
02/02/2012US20120029009 Tacrolimus For Improved Treatment Of Transplant Patients
02/02/2012US20120028995 Novel compounds for medical use as peptidase effectors
02/02/2012US20120028985 Combinational therapy for treating autoimmune disease
02/02/2012US20120028966 Protein kinase inhibitors
02/02/2012US20120028965 Compounds useful as protein kinase inhibitors
02/02/2012US20120028963 Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same
02/02/2012US20120028958 5-alkynyl-pyrimidines
02/02/2012US20120028953 Azetidine Derivatives
02/02/2012US20120028952 5-alkynyl-pyrimidines
02/02/2012US20120028939 Substituted naphthyridines and their use as medicaments
02/02/2012US20120028938 Pyrazole compounds as crth2 antagonists
02/02/2012US20120028923 Compositions and methods for inhibition of the jak pathway
02/02/2012US20120028915 6"-amino-6"-deoxygalactosylceramides
02/02/2012US20120028888 Apj receptor compounds
02/02/2012US20120027852 Pharmaceutical composition containing a "limus" family immunosuppressive macrolide
02/02/2012US20120027811 Formulations of Viable Cells for Oral Delivery
02/02/2012US20120027808 Nicotine immunonanotherapeutics
02/02/2012US20120027803 Biodegradable lipids for the delivery of active agents
02/02/2012US20120027802 Use of common gamma chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes
02/02/2012US20120027801 Polypeptides from neisseria meningitidis
02/02/2012US20120027800 Neisserial vaccine compositions comprising a combination of antigens
02/02/2012US20120027799 Compositions and methods for treating or preventing inflammatory bowel disease and colon cancer
02/02/2012US20120027798 Antibody gene transfer and recombinant aav therefor
02/02/2012US20120027796 Novel lipids and compositions for the delivery of therapeutics
02/02/2012US20120027793 Compositions comprising chlamydia antigens
02/02/2012US20120027792 Expression vectors able to elicit improved immune response and methods of using same
02/02/2012US20120027791 Antisense compound for inducing immunological tolerance
02/02/2012US20120027789 Antigenic peptide of hsv-2 and methods for using same
02/02/2012US20120027788 Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
02/02/2012US20120027787 Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
02/02/2012US20120027786 Genetically programmable pathogen sense and destroy
02/02/2012US20120027777 Ljungan virus with improved replication characteristics
02/02/2012US20120027775 Absorbable peg-based hydrogels
02/02/2012US20120027771 Affinity purified human polyclonal antibodies against viral, bacterial and/or fungal infections and methods of making and using the same
02/02/2012US20120027770 Novel cell and therapeutical and diagnostical methods based thereon
02/02/2012US20120027768 Monoclonal antibody production by ebv transformation of b cells
02/02/2012US20120027761 Treatment of Inflammatory Diseases by Inhibiting Cold-Inducible RNA-Binding Protein (CIRP)
02/02/2012US20120027759 Methods of enhancing t cell responsiveness
02/02/2012US20120027758 Use of anti-cd100 antibodies
02/02/2012US20120027755 Prevention and treatment of alzheimer's disease
02/02/2012US20120027751 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
02/02/2012US20120027748 Immunological reconstitution promoter or prophylactic agent for infections each of which maintains graft-versus-tumor effect
02/02/2012US20120027731 Hemangio-colony forming cells
02/02/2012US20120027730 Uses of mesenchymal stem cells
02/02/2012US20120027722 Hepatitis c virus combination therapy
02/02/2012US20120027718 Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
02/02/2012US20120027690 Ph-sensitive graft copolymer, manufacturing method for same, and polymer micelles using method
02/02/2012US20120027680 Oxime conjugates and methods for their formation and use
02/02/2012US20120027677 Prion-specific peptoid reagents
02/02/2012US20120027674 Il-18 receptor as a novel target of regulatory t cells in cancer
02/02/2012US20120024743 Transdermal pharmaceutical preparations
02/02/2012CA2843265A1 Peripherally restricted faah inhibitors
02/02/2012CA2807097A1 Matrix metalloproteinase inhibitors
02/02/2012CA2806613A1 Recombinant neisseria meningitidis pora porin proteins
02/02/2012CA2806536A1 Recombinant bacterium and uses thereof
02/02/2012CA2804199A1 Compositions and methods for inhibition of the jak pathway
02/01/2012EP2412811A1 Dna vaccine for alzheimer's disease
02/01/2012EP2412797A1 Process for producing lactic acid bacterium having enhanced immunomodulating activity
02/01/2012EP2412716A1 Partial and full agonists of A1 adenosine receptors
02/01/2012EP2412707A2 3-[2-(3-Amino-2-oxo-2H-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
02/01/2012EP2411521A1 Compositions for stimulation of mammalian innate immune resistance to pathogens
02/01/2012EP2410996A2 Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
02/01/2012EP2107907B1 Combination of pemirolast and ramatroban for use in the treatment of inflammatory disorders
02/01/2012EP2066319B1 Benzotriazole kinase modulators
02/01/2012EP1848719B1 [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
02/01/2012EP1817301B1 Potentiators of glutamate receptors
02/01/2012EP1699925B1 DCRS5 and p19 antagonists for therapy of asthma, allergy and COPD
02/01/2012EP1511725B1 24-sulfoximine vitamin d3 compounds
02/01/2012EP1429803B1 Anti-coronavirus vaccine
02/01/2012EP1286989B1 Prodrug of an ICE inhibitor
1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 1172